Baxter International (NYSE:BAX) Issues FY 2025 Earnings Guidance

Baxter International (NYSE:BAX) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 2.450-2.550 for the period, compared to the consensus earnings per share estimate of 2.460. The company issued revenue guidance of $11.2 billion-$11.3 billion, compared to the consensus revenue estimate of $11.2 billion. Baxter International also updated its Q1 2025 guidance to 0.470-0.500 EPS.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. StockNews.com downgraded Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, November 11th. Barclays began coverage on shares of Baxter International in a research note on Thursday. They issued an “overweight” rating and a $39.00 price target for the company. Citigroup reduced their price objective on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, December 11th. JPMorgan Chase & Co. dropped their target price on shares of Baxter International from $38.00 to $36.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Stifel Nicolaus reduced their price target on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $38.80.

Baxter International Price Performance

Shares of BAX opened at $33.87 on Friday. The firm has a market capitalization of $17.29 billion, a price-to-earnings ratio of -26.46, a price-to-earnings-growth ratio of 10.62 and a beta of 0.61. The stock’s fifty day moving average is $30.65 and its 200-day moving average is $34.14. Baxter International has a one year low of $28.33 and a one year high of $44.01. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.09 and a current ratio of 1.43.

Baxter International (NYSE:BAX) last released its quarterly earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. The company had revenue of $2.75 billion for the quarter, compared to the consensus estimate of $2.67 billion. Baxter International had a negative net margin of 5.05% and a positive return on equity of 16.67%. Equities analysts anticipate that Baxter International will post 2.48 EPS for the current year.

Baxter International Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Friday, February 28th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.68 annualized dividend and a dividend yield of 2.01%. Baxter International’s dividend payout ratio (DPR) is -53.13%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.